Question 1

Am I eligible for this trial based on my migraine history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine clinical trial (NCT05748483). Contact the study team or your healthcare provider for specific answers.

Question 2

How does atogepant compare to my current migraine treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine clinical trial (NCT05748483). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of atogepant and topiramate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine clinical trial (NCT05748483). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine clinical trial (NCT05748483). Contact the study team or your healthcare provider for specific answers.

Question 5

What will the treatment process look like over the 24 weeks?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine clinical trial (NCT05748483). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I be monitored for any side effects during and after the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine clinical trial (NCT05748483). Contact the study team or your healthcare provider for specific answers.

What this study is about